<DOC>
	<DOCNO>NCT01979861</DOCNO>
	<brief_summary>The purpose study determine AEGEA Vapor System endometrial ablation safe effective reduce menstrual blood loss woman excessive uterine bleeding ( menorrhagia )</brief_summary>
	<brief_title>Safety &amp; Effectiveness Study AEGEA Vapor System Treat Excessive Uterine Bleeding</brief_title>
	<detailed_description>This single-arm , multi-center study three year follow-up .</detailed_description>
	<mesh_term>Menorrhagia</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<criteria>Female subject ( include ) age 30 50 year Selfreported history heavy menstrual bleeding least 3 last 6 month Predictable cyclic menstrual cycle past 6 month Excessive uterine bleeding Premenopausal enrollment Normal PAP Normal endometrial biopsy Willing use reliable contraception Not currently take hormonal medication Agree use sponsor provide catamenial product ( sanitary pads/tampons ) Pregnant Desires future childbearing Presence IUD Previous endometrial ablation procedure Evidence STI Evidence PID Active infection genitals , vagina , cervix , uterus urinary tract Active endometritis Active bacteremia , sepsis active systemic infection Gynecologic malignancy Endometrial hyperplasia Known clotting defect bleed disorder On anticoagulant therapy Hemoglobin &lt; 8gm/dl Prior uterine surgery Currently medication could thin myometrial muscle Severe dysmenorrhea , secondary adenomyosis Abnormal uterine cavity Hydrosalpinx Uterine length &lt; 6cm &gt; 12cm Currently clinical trial</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Endometrial ablation vapor</keyword>
</DOC>